Incident users of tyrosine kinase inhibitors in patients with chronic myeloid leukemia: Analysis of anticancer treatment trajectories-A French population-based study using the French national health data system

被引：2
|
作者：
Vabre, Clementine [1 ,2 ]
Zelmat, Yoann [3 ]
Gauthier, Martin [4 ,5 ]
Pajiep, Marie [3 ]
Conte, Cecile [3 ]
Lapeyre-Mestre, Maryse [2 ,3 ]
Dray-Spira, Rosemary [1 ]
Zureik, Mahmoud [1 ]
Despas, Fabien [2 ,3 ,6 ]
机构：
[1] French Natl Agcy Safety Med & Hlth Prod & French, EPI PHARE Sci Interest Grp Epidemiol Hlth Prod, Paris, France
[2] Univ Paul Sabatier Toulouse, Toulouse Univ Hosp, INSERM, Equipe PEPS,CIC 1436, Toulouse, France
[3] Toulouse Univ Hosp, Fac Med, Ctr PharmacoVigilance & Pharmacoepidemiol, Dept Med & Clin Pharmacol, Toulouse, France
[4] Toulouse Univ Hosp, Inst Univ Canc Oncopole, Dept Hematol, Toulouse, France
[5] Cahors Hosp, Dept Hematol, Cahors, France
[6] Univ Toulouse III, Inst Malad Metabol & Cardiovasc I2MC, UMR1297, INSERM DR Midi Pyrenees Limousin, Toulouse, France
来源：
AMERICAN JOURNAL OF HEMATOLOGY | 2022年 / 97卷 / 08期
关键词：
D O I：
10.1002/ajh.26621
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E307 / E309
页数：3
相关论文
共 37 条
  • [31] Five-Year Overall Survival Analysis Using First- and Second-Generation Tyrosine Kinase Inhibitors in Patients with Chronic Myeloid Leukemia in the Chronic Phase in a Prospective Observational Study (SIMPLICITY)
    Mauro, Michael
    Paquette, Ronald
    Hehlmann, Rudiger
    Williams, Loretta A.
    Goldberg, Stuart L.
    Michallet, Mauricette
    Gambacorti-Passerini, Carlo
    Tang, Derek
    DeGutis, Irene S.
    McBride, Ali
    Parsons, Lori
    Montelongo, Monica Z.
    Cortes, Jorge E.
    BLOOD, 2022, 140 : 9624 - 9625
  • [32] Real World Population- Based Data from Nationwide Registry Support the Existence of Accelerated Phase in Newly Diagnosed Chronic Myeloid Leukemia (CML) Patients Even in Tyrosine Kinase Inhibitors (TKIs) Era
    Hornak, Tomas
    Mayer, Jiri
    Cicatkova, Petra
    Semerad, Lukas
    Kvetkova, Anezka
    Klamova, Hana
    Faber, Edgar
    Belohlavkova, Petra
    Karas, Michal
    Stejskal, Lukas
    Cmunt, Eduard
    Cerna, Olga
    Srbova, Dana
    Zizkova, Hana
    Vrablova, Lucia
    Skoumalova, Ivana
    Voglova, Jaroslava
    Jurkova, Tereza
    Chrapava, Marika
    Jurcek, Tomas
    Jeziskova, Ivana
    Jarosova, Marie
    Polakova, Katerina Machova
    Papajik, Tomas
    Zak, Pavel
    Jindra, Pavel
    Zackova, Daniela
    BLOOD, 2023, 142
  • [33] Incidence of chronic end-stage renal disease in patients with inflammatory bowel disease: a population-based cohort study from the French National Health Insurance Database.
    Prothe, C.
    Boitel, A.
    Martin, B.
    Clairet, V.
    Juif, L.
    Lang, S.
    Koch, S.
    Ducloux, D.
    Desmarets, M.
    Vuitton, L.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I884 - I884
  • [34] Adverse Events and Treatment Adjustments Among Newly Diagnosed Patients with Chronic Myeloid Leukemia Treated with Tyrosine Kinase Inhibitors: A Comprehensive Data Analysis of Medicare Fee-for-Service and Commercial Plans in the United States
    Jabbour, Elias
    Wei, David
    Yang, Hongbo
    Jadhav, Kejal
    Song, Wei
    Zhao, Yajin
    Shao, Anran
    Tomicki, Samantha
    Yang, Daisy
    Damon, Andrea
    Sadek, Islam
    Kota, Vamsi K.
    BLOOD, 2024, 144 : 2434 - 2435
  • [35] BARODELTA STUDY : REAL WORLD DATA ( RWD) OF 498 UNIQUE PATIENTS WITH CHRONIC HEPATITIS DELTA TREATED WITH BULEVIRTIDE ( BLV) 2 MG. ANALYSIS FROM THE FRENCH NATIONAL HEALTH DATA SYSTEM ( SNDS)
    Asselah, Tarik
    Loustaud-Ratti, Veronique
    Bronowicki, Jean-Pierre
    Gordien, Emmanuel
    Maugain, Estelle
    Le Blevev, Audrey
    Idelovici-Marchal, Claire
    Lacueille, Clementine
    Lemaitre, Magali
    Bazin, Fabienne
    Colombi, Charlotte
    HEPATOLOGY, 2024, 80 : S112 - S112
  • [36] Risk of new-onset hypertension in patients (pts) with newly diagnosed chronic lymphocytic leukemia (CLL) treated with Bruton tyrosine kinase inhibitors (BTKi): A real-world data study using the Symphony Health Solution database
    Kou, Tzuyung Douglas
    Zhou, Lili
    Zhou, Jinzhi
    Cohen, Aileen
    Aldairy, Wassim
    White, William B.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [37] Sustained Efficacy and Safety with Asciminib (ASC) after Almost 4 Years of Median Followup from Ascembl, a Phase 3 Study of ASC Vs Bosutinib (BOS) in Patients (Pts) with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) after ≥2 Prior Tyrosine Kinase Inhibitors (TKIs): An End of Study Treatment (EOS Tx) Update, Including Results from Switch Population
    Mauro, Michael
    Minami, Yosuke
    Hochhaus, Andreas
    Lomaia, Elza
    Voloshin, Sergei
    Turkina, Anna
    Kim, Dong-Wook
    Apperley, Jane F.
    Cortes, Jorge
    Abdo, Andre N. R.
    Fogliatto, Laura Maria
    Kim, Dennis Dong Hwan
    le Coutre, Philipp
    Saussele, Susanne
    Annunziata, Mario
    Hughes, Timothy P.
    Chaudhri, Naeem A.
    Chee, Lynette C. Y.
    Gutierrez, Valentin Garcia
    Sasaki, Koji
    Freitas, Carla Maria Boquimpani De Moura
    Kapoor, Shruti
    Espurz, Noemi
    Dhamal, Vishal
    Rea, Delphine
    BLOOD, 2023, 142
1234